Notice of Application - 2012
[Federal Register Volume 77, Number 218 (Friday, November 9, 2012)]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27400]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application; INB
Hauser Pharmaceutical Services, Inc.
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on September 20, 2012, InB
Hauser Pharmaceutical Services, Inc., 6880 N. Broadway, Suite H,
Denver, Colorado 80221, made application by letter to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of 4-Anilino-N-phenethyl-4-piperidine (8333), a basic
class of controlled substance listed in schedule II.
The company plans to manufacture the listed controlled substance in
bulk for distribution and sale to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substance, may file comments or
objections to the issuance of the proposed registration pursuant to 21
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 8, 2013.
Dated: November 1, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
[FR Doc. 2012-27400 Filed 11-8-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).